RGD delivery of truncated coagulase to tumor vasculature affords local thrombotic activity to induce infarction of tumors in mice
Abstract Induction of thrombosis in tumor vasculature represents an appealing strategy for combating cancer. Herein, we combined unique intrinsic coagulation properties of staphylocoagulase with new acquired functional potentials introduced by genetic engineering, to generate a novel bi-functional f...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b5881d644e7d46bf881e23c2c471dc2b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:b5881d644e7d46bf881e23c2c471dc2b |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:b5881d644e7d46bf881e23c2c471dc2b2021-12-02T12:32:39ZRGD delivery of truncated coagulase to tumor vasculature affords local thrombotic activity to induce infarction of tumors in mice10.1038/s41598-017-05326-92045-2322https://doaj.org/article/b5881d644e7d46bf881e23c2c471dc2b2017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-05326-9https://doaj.org/toc/2045-2322Abstract Induction of thrombosis in tumor vasculature represents an appealing strategy for combating cancer. Herein, we combined unique intrinsic coagulation properties of staphylocoagulase with new acquired functional potentials introduced by genetic engineering, to generate a novel bi-functional fusion protein consisting of truncated coagulase (tCoa) bearing an RGD motif on its C-terminus for cancer therapy. We demonstrated that free coagulase failed to elicit any significant thrombotic activity. Conversely, RGD delivery of coagulase retained coagulase activity and afforded favorable interaction of fusion proteins with prothrombin and αvβ3 endothelial cell receptors, as verified by in silico, in vitro, and in vivo experiments. Although free coagulase elicited robust coagulase activity in vitro, only targeted coagulase (tCoa-RGD) was capable of producing extensive thrombosis, and subsequent infarction and massive necrosis of CT26 mouse colon, 4T1 mouse mammary and SKOV3 human ovarian tumors in mice. Additionally, systemic injections of lower doses of tCoa-RGD produced striking tumor growth inhibition of CT26, 4T1 and SKOV3 solid tumors in animals. Altogether, the nontoxic nature, unique shortcut mechanism, minimal effective dose, wide therapeutic window, efficient induction of thrombosis, local effects and susceptibility of human blood to coagulase suggest tCoa-RGD fusion proteins as a novel and promising anticancer therapy for human trials.Rana Jahanban-EsfahlanKhaled SeidiHassan MonhemiAmir Daei Farshchi AdliBabak MinofarPeyman ZareDavoud FarajzadehSafar FarajniaRamezan BehzadiMehran Mesgari AbbasiNosratollah ZarghamiTahereh JavaheriNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-14 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Rana Jahanban-Esfahlan Khaled Seidi Hassan Monhemi Amir Daei Farshchi Adli Babak Minofar Peyman Zare Davoud Farajzadeh Safar Farajnia Ramezan Behzadi Mehran Mesgari Abbasi Nosratollah Zarghami Tahereh Javaheri RGD delivery of truncated coagulase to tumor vasculature affords local thrombotic activity to induce infarction of tumors in mice |
description |
Abstract Induction of thrombosis in tumor vasculature represents an appealing strategy for combating cancer. Herein, we combined unique intrinsic coagulation properties of staphylocoagulase with new acquired functional potentials introduced by genetic engineering, to generate a novel bi-functional fusion protein consisting of truncated coagulase (tCoa) bearing an RGD motif on its C-terminus for cancer therapy. We demonstrated that free coagulase failed to elicit any significant thrombotic activity. Conversely, RGD delivery of coagulase retained coagulase activity and afforded favorable interaction of fusion proteins with prothrombin and αvβ3 endothelial cell receptors, as verified by in silico, in vitro, and in vivo experiments. Although free coagulase elicited robust coagulase activity in vitro, only targeted coagulase (tCoa-RGD) was capable of producing extensive thrombosis, and subsequent infarction and massive necrosis of CT26 mouse colon, 4T1 mouse mammary and SKOV3 human ovarian tumors in mice. Additionally, systemic injections of lower doses of tCoa-RGD produced striking tumor growth inhibition of CT26, 4T1 and SKOV3 solid tumors in animals. Altogether, the nontoxic nature, unique shortcut mechanism, minimal effective dose, wide therapeutic window, efficient induction of thrombosis, local effects and susceptibility of human blood to coagulase suggest tCoa-RGD fusion proteins as a novel and promising anticancer therapy for human trials. |
format |
article |
author |
Rana Jahanban-Esfahlan Khaled Seidi Hassan Monhemi Amir Daei Farshchi Adli Babak Minofar Peyman Zare Davoud Farajzadeh Safar Farajnia Ramezan Behzadi Mehran Mesgari Abbasi Nosratollah Zarghami Tahereh Javaheri |
author_facet |
Rana Jahanban-Esfahlan Khaled Seidi Hassan Monhemi Amir Daei Farshchi Adli Babak Minofar Peyman Zare Davoud Farajzadeh Safar Farajnia Ramezan Behzadi Mehran Mesgari Abbasi Nosratollah Zarghami Tahereh Javaheri |
author_sort |
Rana Jahanban-Esfahlan |
title |
RGD delivery of truncated coagulase to tumor vasculature affords local thrombotic activity to induce infarction of tumors in mice |
title_short |
RGD delivery of truncated coagulase to tumor vasculature affords local thrombotic activity to induce infarction of tumors in mice |
title_full |
RGD delivery of truncated coagulase to tumor vasculature affords local thrombotic activity to induce infarction of tumors in mice |
title_fullStr |
RGD delivery of truncated coagulase to tumor vasculature affords local thrombotic activity to induce infarction of tumors in mice |
title_full_unstemmed |
RGD delivery of truncated coagulase to tumor vasculature affords local thrombotic activity to induce infarction of tumors in mice |
title_sort |
rgd delivery of truncated coagulase to tumor vasculature affords local thrombotic activity to induce infarction of tumors in mice |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/b5881d644e7d46bf881e23c2c471dc2b |
work_keys_str_mv |
AT ranajahanbanesfahlan rgddeliveryoftruncatedcoagulasetotumorvasculatureaffordslocalthromboticactivitytoinduceinfarctionoftumorsinmice AT khaledseidi rgddeliveryoftruncatedcoagulasetotumorvasculatureaffordslocalthromboticactivitytoinduceinfarctionoftumorsinmice AT hassanmonhemi rgddeliveryoftruncatedcoagulasetotumorvasculatureaffordslocalthromboticactivitytoinduceinfarctionoftumorsinmice AT amirdaeifarshchiadli rgddeliveryoftruncatedcoagulasetotumorvasculatureaffordslocalthromboticactivitytoinduceinfarctionoftumorsinmice AT babakminofar rgddeliveryoftruncatedcoagulasetotumorvasculatureaffordslocalthromboticactivitytoinduceinfarctionoftumorsinmice AT peymanzare rgddeliveryoftruncatedcoagulasetotumorvasculatureaffordslocalthromboticactivitytoinduceinfarctionoftumorsinmice AT davoudfarajzadeh rgddeliveryoftruncatedcoagulasetotumorvasculatureaffordslocalthromboticactivitytoinduceinfarctionoftumorsinmice AT safarfarajnia rgddeliveryoftruncatedcoagulasetotumorvasculatureaffordslocalthromboticactivitytoinduceinfarctionoftumorsinmice AT ramezanbehzadi rgddeliveryoftruncatedcoagulasetotumorvasculatureaffordslocalthromboticactivitytoinduceinfarctionoftumorsinmice AT mehranmesgariabbasi rgddeliveryoftruncatedcoagulasetotumorvasculatureaffordslocalthromboticactivitytoinduceinfarctionoftumorsinmice AT nosratollahzarghami rgddeliveryoftruncatedcoagulasetotumorvasculatureaffordslocalthromboticactivitytoinduceinfarctionoftumorsinmice AT taherehjavaheri rgddeliveryoftruncatedcoagulasetotumorvasculatureaffordslocalthromboticactivitytoinduceinfarctionoftumorsinmice |
_version_ |
1718394001231446016 |